Matthew Priest

663 total citations
11 papers, 152 citations indexed

About

Matthew Priest is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Matthew Priest has authored 11 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in Matthew Priest's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Liver Disease and Transplantation (3 papers). Matthew Priest is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Liver Disease and Transplantation (3 papers). Matthew Priest collaborates with scholars based in United Kingdom and United States. Matthew Priest's co-authors include Robert M. Jackson, Subrata Ghosh, Margaret McIntyre, Simon Campbell, Anna Dahele, Ian Arnott, Helen Gillett, Stephen T. Barclay, Andrew Fraser and George Abouda and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Digestive Diseases and Sciences.

In The Last Decade

Matthew Priest

9 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Priest United Kingdom 5 121 97 53 34 28 11 152
Yifat Snir Israel 7 34 0.3× 20 0.2× 57 1.1× 31 0.9× 41 1.5× 25 139
Marco Rais Italy 5 57 0.5× 31 0.3× 18 0.3× 19 0.6× 8 0.3× 12 98
Eva Martínez‐Ojinaga Spain 7 83 0.7× 97 1.0× 75 1.4× 5 0.1× 36 1.3× 14 166
Shuji Kochi Japan 8 29 0.2× 42 0.4× 62 1.2× 3 0.1× 35 1.3× 13 140
Isabel Filipe United Kingdom 8 111 0.9× 29 0.3× 145 2.7× 7 0.2× 130 4.6× 9 257
Marina Leoni Italy 4 138 1.1× 22 0.2× 77 1.5× 8 0.2× 171 6.1× 5 218
Laurent Peyrin-Biroulet France 7 66 0.5× 15 0.2× 41 0.8× 4 0.1× 102 3.6× 43 151
Matteo Bosani Italy 6 102 0.8× 23 0.2× 73 1.4× 4 0.1× 75 2.7× 8 177
Nabil Debzi Algeria 7 83 0.7× 14 0.1× 53 1.0× 91 2.7× 8 0.3× 15 140
Catarina Gomes Portugal 9 24 0.2× 125 1.3× 152 2.9× 7 0.2× 16 0.6× 36 210

Countries citing papers authored by Matthew Priest

Since Specialization
Citations

This map shows the geographic impact of Matthew Priest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Priest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Priest more than expected).

Fields of papers citing papers by Matthew Priest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Priest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Priest. The network helps show where Matthew Priest may publish in the future.

Co-authorship network of co-authors of Matthew Priest

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Priest. A scholar is included among the top collaborators of Matthew Priest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Priest. Matthew Priest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Barclay, Stephen, Matthew Priest, Ewan Forrest, et al.. (2024). Comparison between patient characteristics, aetiology and outcomes in patients with and without cirrhosis with hepatocellular carcinoma diagnosed in a regional centre. Frontline Gastroenterology. 15(5). 380–386. 1 indexed citations
2.
McLaren, Alistair S., Douglas Cartwright, Stephen T. Barclay, et al.. (2023). Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study. BMJ Open Gastroenterology. 10(1). e001231–e001231.
3.
4.
Priest, Matthew, et al.. (2022). Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm. Digestive Diseases and Sciences. 68(3). 770–777. 6 indexed citations
5.
Stanley, Adrian J., et al.. (2021). The association between deprivation and the incidence and survival of patients with hepatocellular carcinoma in the West of Scotland. Expert Review of Gastroenterology & Hepatology. 15(12). 1427–1433. 4 indexed citations
6.
Barclay, Stephen T., et al.. (2021). P221 Non-cirrhotic vs Cirrhotic HCC: comparison between patient characteristics, aetiology and outcomes. A157.2–A158. 1 indexed citations
7.
MacGregor, Gordon, et al.. (2021). P061 The prevalence and monitoring of cirrhotic and non-cirrhotic cystic fibrosis liver disease in an adult West of Scotland cohort. Discovery Research Portal (University of Dundee). A46.1–A46. 1 indexed citations
8.
Barclay, Stephen, Erica N. Peters, Natasha McDonald, et al.. (2020). Patients with hepatitis C (Redpath): a randomised controlled trial of telephone contact or offer of an incentive, in addition to a standard letter. Journal of Hepatology. 73. S328–S328. 2 indexed citations
9.
Boyle, Alison, Fiona Marra, T. Ritchíe, et al.. (2019). Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis. Journal of Viral Hepatitis. 27(4). 371–375. 4 indexed citations
10.
Macken, Lucia, William Gelson, Matthew Priest, et al.. (2019). Efficacy of direct‐acting antivirals: UK real‐world data from a well‐characterised predominantly cirrhotic HCV cohort. Journal of Medical Virology. 91(11). 1979–1988. 21 indexed citations
11.
Gillett, Helen, Ian Arnott, Margaret McIntyre, et al.. (2002). Successful infliximab treatment for steroid-refractory celiac disease: A case report. Gastroenterology. 122(3). 800–805. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yifat Snir Breakdown of academic impact, for papers by Marco Rais Breakdown of academic impact, for papers by Eva Martínez‐Ojinaga Breakdown of academic impact, for papers by Shuji Kochi Breakdown of academic impact, for papers by Isabel Filipe Breakdown of academic impact, for papers by Marina Leoni Breakdown of academic impact, for papers by Laurent Peyrin-Biroulet Breakdown of academic impact, for papers by Matteo Bosani Breakdown of academic impact, for papers by Nabil Debzi Breakdown of academic impact, for papers by Catarina Gomes
Rankless by CCL
2026